Steffen Flindt Nielsen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 10

Top Topics

Randomized Controlled Trial

Skeletal Muscle

Hypertensive Patients

Top Venues

JMIR research protocols

Journal of the American Heart Association

This page only lists publications with an associated author ORCID identifier.

Publications

Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association 13 (12) (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Camilla Lundgreen Duus, Steffen Flindt Nielsen, Bodil Gade Hornstrup, Frank Holden Mose, Jesper Nørgaard Bech
Self-Performed Dietary Sodium Reduction and Blood Pressure in Patients With Essential Hypertension: A Randomized Clinical Trial. Journal of the American Heart Association (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)
Steffen Flindt Nielsen, Camilla Lundgreen Duus, Niels Henrik Buus, Jesper Nørgaard Bech, Frank Holden Mose
Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project). JMIR research protocols 13 (2024)